Fig. 3From: A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesotheliomaHE staining and IHC staining of tumor tissue from the original patient and PDX1 model (P3). For original tumor: (A) HE staining, (B-E) CR, CK5/6, WT1, and D2-40 positive (F) TTF1 negative; for PDX1’s tumor: (G) HE staining, (H-K) CR, CK5/6, WT1, and D2-40 positive, (L) PAX8 negative (original magnification ×400)Back to article page